NovaBay Pharmaceuticals, Inc Stock Prediction and Forecast [NBY]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 10 Jan 2026, 04:31 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for NovaBay Pharmaceuticals, Inc Stock Prediction and Forecast [NBY]](https://i.ytimg.com/vi/pS8Av3cx1GQ/hqdefault.jpg)
AI-generated source summary
NovaBay Pharmaceuticals (NBY) shows several positive signals, including short-term and long-term moving average buy signals, and a recent pivot bottom formation. The stock's RSI is at 88, indicating potential overbought conditions and increased risk. While the stock has experienced significant daily movements and has a high weekly volatility of 50.63%, suggesting a very high risk profile, recent insider buying activity and a strong upward trend indicate potential for further gains. However, due to some technical weaknesses and the current overvalued price-to-earnings ratio, the stock is considered a hold candidate, with a projected opening price down $2.94 to $16.22 on Monday, January 12th, 2026. Potential support levels are identified at $9.27 and $3.91. Trading below these levels would signal a sell. Future price action is uncertain, with a projected range between $3.14 and $19.82 over the next year.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.